These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 16635509

  • 21. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.
    Finazzi-Agrò E, Peppe A, D'Amico A, Petta F, Mazzone P, Stanzione P, Micali F, Caltagirone C.
    J Urol; 2003 Apr; 169(4):1388-91. PubMed ID: 12629368
    [Abstract] [Full Text] [Related]

  • 22. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
    Choe JH, Choo MS, Lee KS.
    J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
    [Abstract] [Full Text] [Related]

  • 23. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P.
    Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele.
    Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H.
    Neurourol Urodyn; 2006 Mar; 25(4):361-7. PubMed ID: 16721816
    [Abstract] [Full Text] [Related]

  • 27. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity.
    Cucchi A, Quaglini S, Rovereto B.
    J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The Effect of Pelvic Floor Muscle Contraction on Detrusor Overactivity Pressure in Neurogenic and Nonneurogenic Women During Urodynamic Study: A Cross-Sectional Study.
    Lúcio A, Lourenço CB, Damasceno BP, de Moraes Lopes MHB, Dʼancona CAL.
    Am J Phys Med Rehabil; 2019 Apr; 98(4):275-279. PubMed ID: 30893073
    [Abstract] [Full Text] [Related]

  • 30. Is there any association between urodynamic variables and severity of overactive bladder in women with idiopathic detrusor overactivity?
    Giarenis I, Zacchè M, Robinson D, Cardozo L.
    Neurourol Urodyn; 2017 Mar; 36(3):780-783. PubMed ID: 27092808
    [Abstract] [Full Text] [Related]

  • 31. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders.
    Mukerji G, Waters J, Chessell IP, Bountra C, Agarwal SK, Anand P.
    BMC Urol; 2006 Dec 27; 6():31. PubMed ID: 17192176
    [Abstract] [Full Text] [Related]

  • 32. [Overactive bladder: urodynamic characteristics of detrusor overactivity due to the etiology of low urinary tract dysfun- ction].
    Philippova ES, Bazhenov IV, Ziryanov AV, Zhuravlev VN.
    Urologiia; 2021 Jun 27; (3):39-44. PubMed ID: 34251099
    [Abstract] [Full Text] [Related]

  • 33. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A.
    Clin Neuropharmacol; 2006 Jun 27; 29(4):220-9. PubMed ID: 16855424
    [Abstract] [Full Text] [Related]

  • 34. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.
    J Urol; 2006 Jul 27; 176(1):177-85. PubMed ID: 16753396
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
    Giannitsas K, Perimenis P, Athanasopoulos A, Gyftopoulos K, Nikiforidis G, Barbalias G.
    Eur Urol; 2004 Dec 27; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
    [Abstract] [Full Text] [Related]

  • 36. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar 27; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 37. Effect of antiepileptic agent, levetiracetam, on urodynamic parameters and neurogenic bladder overactivity in chronically paraplegic rats.
    Elzayat EA, Campeau L, Karsenty G, Blok B, Padjen AL, Corcos J.
    Urology; 2009 Apr 27; 73(4):922-7. PubMed ID: 19167033
    [Abstract] [Full Text] [Related]

  • 38. Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia.
    Dong D, Xu Z, Shi B, Chen J, Jiang X, Wang H.
    Neurourol Urodyn; 2006 Apr 27; 25(5):446-50. PubMed ID: 16847921
    [Abstract] [Full Text] [Related]

  • 39. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K.
    Eur Urol; 2008 Aug 27; 54(2):419-26. PubMed ID: 18325657
    [Abstract] [Full Text] [Related]

  • 40. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P.
    BJU Int; 2009 Mar 27; 103(5):630-4. PubMed ID: 18990156
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.